Eledon Pharmaceuticals, Inc. — Form D

Eledon Pharmaceuticals, Inc. of IRVINE, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-22. $35.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (40)

Showing 25 of 40 people.

NameRoleLocation
Gary LyonsDirectorIrvine, CA
John McBrideDirectorToronto, A6
June LeeDirectorBerkeley, CA
Bryan SmithExecutive OfficerNew York, NY
Erez ChimovitsDirectorNESS ZIONA, L3
David KesslerDirectorTROY, MI
CATHERINE TURKELExecutive OfficerKelowna, A1
Keith A KatkinDirectorSan Diego, CA
Steven PerrinDirectorIrvine, CA
Steven PerrinExecutive OfficerIrvine, CA
David-Alexandre GrosDirectorIrvine, CA
David-Alexandre GrosExecutive OfficerIrvine, CA
Allan KirkDirectorIrvine, CA
James RobinsonDirectorMorrisville, NC
Keith KatkinDirectorIrvine, CA
Jan HillsonDirectorIrvine, CA
Paul LittleExecutive OfficerPine Ridge, SD
Walter OgierDirectorIrvine, CA
Reinhard J AmbrosDirectorWaltham, MA
Cheryl CohenDirectorSan Diego, CA
Gregory FlesherDirectorSan Diego, CA
Gregory FlesherExecutive OfficerSan Diego, CA
John A McBrideDirectorIrvine, CA
Steven N PerrinDirectorIrvine, CA
Gary A LyonsDirectorIrvine, CA

Other filings by this issuer (7)

FiledFormOfferingSold
2024-05-23D$50.0M
2020-09-25D$108.1M$108.1M
2020-01-27D$5.8M$862K
2019-05-10D$28.5M$862K
2013-05-15D$35.5M$20.0M
2011-09-20D$23.0M$1.9M
2009-05-06D$22.0M$10.0M

More